Currently, Halozyme Therapeutics has a Zacks Rank of #2 (Buy), while Amicus Therapeutics has a Zacks Rank of #3 (Hold). Investors should feel comfortable knowing that HALO likely has seen a stronger ...
The holidays are here, and so is the season of festive gatherings and delicious feasts! This year, skip the kitchen chaos and bring the magic of Ihaw-Sarap and Unli-Saya to your table with Mang Inasal ...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Halozyme Therapeutics (HALO) and Amicus Therapeutics (FOLD). But which of these two stocks is more ...